Akorn News Headlines (NASDAQ:AKRX)

$4.10
+0.43 (+11.72 %)
(As of 09/22/2019 08:27 AM ET)
Today's Range
$3.64
Now: $4.10
$4.25
50-Day Range
$2.46
MA: $3.04
$4.08
52-Week Range
$2.34
Now: $4.10
$13.37
Volume2.80 million shs
Average Volume2.24 million shs
Market Capitalization$515.99 million
P/E RatioN/A
Dividend YieldN/A
Beta1.91

Headlines

Akorn (NASDAQ AKRX) News Headlines

Source:
DateHeadline
Akorn (NASDAQ:AKRX) Given New $4.00 Price Target at SunTrust BanksAkorn (NASDAQ:AKRX) Given New $4.00 Price Target at SunTrust Banks
www.americanbankingnews.com - September 20 at 11:03 AM
Akorn, Inc. (NASDAQ:AKRX) Sees Significant Growth in Short InterestAkorn, Inc. (NASDAQ:AKRX) Sees Significant Growth in Short Interest
www.americanbankingnews.com - September 15 at 4:51 AM
Zacks: Brokerages Expect Akorn, Inc. (NASDAQ:AKRX) Will Post Quarterly Sales of $175.08 MillionZacks: Brokerages Expect Akorn, Inc. (NASDAQ:AKRX) Will Post Quarterly Sales of $175.08 Million
www.americanbankingnews.com - September 12 at 1:43 AM
 Brokerages Anticipate Akorn, Inc. (NASDAQ:AKRX) Will Announce Earnings of -$0.04 Per Share Brokerages Anticipate Akorn, Inc. (NASDAQ:AKRX) Will Announce Earnings of -$0.04 Per Share
www.americanbankingnews.com - September 10 at 10:12 PM
Akorn And Its Growing Problems - Seeking AlphaAkorn And Its Growing Problems - Seeking Alpha
seekingalpha.com - September 10 at 6:51 PM
Akorn, Inc. (NASDAQ:AKRX) Receives Average Recommendation of "Hold" from AnalystsAkorn, Inc. (NASDAQ:AKRX) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 1 at 2:31 AM
FDA OKs Akorn allergic rhinitis nasal spray - Seeking AlphaFDA OKs Akorn allergic rhinitis nasal spray - Seeking Alpha
seekingalpha.com - August 28 at 9:58 AM
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15% - GlobeNewswireAkorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15% - GlobeNewswire
www.globenewswire.com - August 26 at 6:34 PM
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%
finance.yahoo.com - August 26 at 6:33 PM
Is Akorn (NASDAQ:AKRX) A Risky Investment? - Yahoo FinanceIs Akorn (NASDAQ:AKRX) A Risky Investment? - Yahoo Finance
finance.yahoo.com - August 15 at 6:12 PM
Is Akorn (NASDAQ:AKRX) A Risky Investment?Is Akorn (NASDAQ:AKRX) A Risky Investment?
finance.yahoo.com - August 14 at 6:38 PM
Global Blepharitis Drugs Market Outlook 2019-2023 with Akorn, Allergan, Bausch Health Companies, Novartis, and Pfizer Leading the Competition - ResearchAndMarkets.com - Business WireGlobal Blepharitis Drugs Market Outlook 2019-2023 with Akorn, Allergan, Bausch Health Companies, Novartis, and Pfizer Leading the Competition - ResearchAndMarkets.com - Business Wire
www.businesswire.com - August 13 at 9:52 AM
Akorn (AKRX) Management Meetings Imply 2020 Expectations Are an Easy Hurdle - RBC Capital - StreetInsider.comAkorn (AKRX) Management Meetings Imply 2020 Expectations Are an Easy Hurdle - RBC Capital - StreetInsider.com
www.streetinsider.com - August 13 at 9:52 AM
Why would allegedly defrauded Akorn investors want … more Akorn stock? - ReutersWhy would allegedly defrauded Akorn investors want … more Akorn stock? - Reuters
www.reuters.com - August 12 at 11:29 PM
Form 8-K AKORN INC For: Aug 09 - StreetInsider.comForm 8-K AKORN INC For: Aug 09 - StreetInsider.com
www.streetinsider.com - August 12 at 8:01 AM
Edited Transcript of AKRX earnings conference call or presentation 1-Aug-19 1:00pm GMT - Yahoo FinanceEdited Transcript of AKRX earnings conference call or presentation 1-Aug-19 1:00pm GMT - Yahoo Finance
finance.yahoo.com - August 5 at 6:56 PM
Edited Transcript of AKRX earnings conference call or presentation 1-Aug-19 1:00pm GMTEdited Transcript of AKRX earnings conference call or presentation 1-Aug-19 1:00pm GMT
finance.yahoo.com - August 5 at 6:56 PM
Akorn Provides Preliminary Second Quarter 2019 ResultsAkorn Provides Preliminary Second Quarter 2019 Results
www.nasdaq.com - August 3 at 12:37 AM
Akorn (AKRX) Q2 2019 Earnings Call Transcript - Yahoo FinanceAkorn (AKRX) Q2 2019 Earnings Call Transcript - Yahoo Finance
finance.yahoo.com - August 2 at 9:00 AM
Akorn (AKRX) Q2 2019 Earnings Call TranscriptAkorn (AKRX) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 2 at 9:00 AM
Akorn (AKRX) Tops Q2 EPS by 5c, Offers Guidance - StreetInsider.comAkorn (AKRX) Tops Q2 EPS by 5c, Offers Guidance - StreetInsider.com
www.streetinsider.com - August 1 at 7:00 PM
Akorn, Inc. (AKRX) CEO Douglas Boothe on Q2 2019 Results - Earnings Call Transcript - Seeking AlphaAkorn, Inc. (AKRX) CEO Douglas Boothe on Q2 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 1 at 7:00 PM
Akorn up 6% premarket on Q2 beat - Seeking AlphaAkorn up 6% premarket on Q2 beat - Seeking Alpha
seekingalpha.com - August 1 at 10:05 AM
Akorn Provides Preliminary Second Quarter 2019 Results Nasdaq:AKRX - GlobeNewswireAkorn Provides Preliminary Second Quarter 2019 Results Nasdaq:AKRX - GlobeNewswire
www.globenewswire.com - August 1 at 10:05 AM
Akorn (AKRX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo FinanceAkorn (AKRX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - August 1 at 10:05 AM
Akorn (AKRX) Reports Q2 Loss, Tops Revenue EstimatesAkorn (AKRX) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 1 at 10:05 AM
Analysts Estimate Akorn (AKRX) to Report a Decline in Earnings: What to Look Out for - Yahoo FinanceAnalysts Estimate Akorn (AKRX) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
finance.yahoo.com - July 25 at 5:45 PM
Analysts Estimate Akorn (AKRX) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Akorn (AKRX) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - July 25 at 5:45 PM
Akorn to Report Second Quarter 2019 Financial Results and Host Conference Call - GlobeNewswireAkorn to Report Second Quarter 2019 Financial Results and Host Conference Call - GlobeNewswire
globenewswire.com - July 12 at 9:21 AM
Akorn to Report Second Quarter 2019 Financial Results and Host Conference Call - Yahoo FinanceAkorn to Report Second Quarter 2019 Financial Results and Host Conference Call - Yahoo Finance
finance.yahoo.com - July 11 at 5:25 PM
Akorn to Report Second Quarter 2019 Financial Results and Host Conference CallAkorn to Report Second Quarter 2019 Financial Results and Host Conference Call
finance.yahoo.com - July 11 at 5:25 PM
Quality Failures at Generic Drug Maker Put Patients at Risk, FDA Warns - BloombergQuality Failures at Generic Drug Maker Put Patients at Risk, FDA Warns - Bloomberg
www.bloomberg.com - July 9 at 5:44 PM
See what the IHS Markit Score report has to say about Akorn Inc.See what the IHS Markit Score report has to say about Akorn Inc.
finance.yahoo.com - July 9 at 9:31 AM
Akorn (AKRX) Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5% - StreetInsider.comAkorn (AKRX) Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5% - StreetInsider.com
www.streetinsider.com - June 30 at 4:59 PM
Akorn Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5% - GlobeNewswireAkorn Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5% - GlobeNewswire
globenewswire.com - June 28 at 9:23 AM
Akorn Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%Akorn Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%
finance.yahoo.com - June 28 at 9:23 AM
Did Hedge Funds Drop The Ball On Akorn, Inc. (AKRX) ? - Yahoo FinanceDid Hedge Funds Drop The Ball On Akorn, Inc. (AKRX) ? - Yahoo Finance
finance.yahoo.com - June 27 at 5:43 PM
Akorn shares halted pending news - Seeking AlphaAkorn shares halted pending news - Seeking Alpha
seekingalpha.com - June 27 at 9:34 AM
Generics maker Akorn receives warning letter from the FDA relating to NJ facility - MarketWatchGenerics maker Akorn receives warning letter from the FDA relating to NJ facility - MarketWatch
www.marketwatch.com - June 26 at 5:37 PM
Akorn gets FDA warning letter related to New Jersey plant - ReutersAkorn gets FDA warning letter related to New Jersey plant - Reuters
www.reuters.com - June 25 at 6:18 PM
Decrying M&A class action ‘racket,’ judge tosses shareholders’ deal with Akorn - ReutersDecrying M&A class action ‘racket,’ judge tosses shareholders’ deal with Akorn - Reuters
www.reuters.com - June 25 at 6:18 PM
Akorn gets FDA warning letter for another manufacturing plant - ReutersAkorn gets FDA warning letter for another manufacturing plant - Reuters
www.reuters.com - June 25 at 6:18 PM
Akorn gets FDA warning letter for another manufacturing plantAkorn gets FDA warning letter for another manufacturing plant
finance.yahoo.com - June 25 at 6:18 PM
Akorn Receives FDA Warning Letter, Says Its Committed To Resolving IssuesAkorn Receives FDA Warning Letter, Says It's Committed To Resolving Issues
finance.yahoo.com - June 25 at 6:18 PM
U.S. STOCKS ON THE MOVE-Allergan, Akorn, Brighthouse - NasdaqU.S. STOCKS ON THE MOVE-Allergan, Akorn, Brighthouse - Nasdaq
www.nasdaq.com - June 25 at 10:27 AM
UPDATE 1-Akorn gets FDA warning letter related to New Jersey plant - Yahoo FinanceUPDATE 1-Akorn gets FDA warning letter related to New Jersey plant - Yahoo Finance
finance.yahoo.com - June 25 at 10:27 AM
Akorn Receives FDA Warning Letter Nasdaq:AKRX - GlobeNewswireAkorn Receives FDA Warning Letter Nasdaq:AKRX - GlobeNewswire
www.globenewswire.com - June 25 at 10:27 AM
Form 8-K AKORN INC For: Jun 25 - StreetInsider.comForm 8-K AKORN INC For: Jun 25 - StreetInsider.com
www.streetinsider.com - June 25 at 10:27 AM
Akorn gets another FDA warning letter, shares slide - ReutersAkorn gets another FDA warning letter, shares slide - Reuters
www.reuters.com - June 25 at 10:27 AM
Generics maker Akorn receives warning letter from the FDA relating to NJ facilityGenerics maker Akorn receives warning letter from the FDA relating to NJ facility
finance.yahoo.com - June 25 at 10:27 AM
This page was last updated on 9/22/2019 by MarketBeat.com Staff

Featured Article: What is a Derivative?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel